181 related articles for article (PubMed ID: 29449436)
41. Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis.
Lwin T; Crespo LA; Wu A; Dessureault S; Shu HB; Moscinski LC; Sotomayor E; Dalton WS; Tao J
Leukemia; 2009 Jan; 23(1):170-7. PubMed ID: 18843286
[TBL] [Abstract][Full Text] [Related]
42. Sorafenib inhibits cell migration and stroma-mediated bortezomib resistance by interfering B-cell receptor signaling and protein translation in mantle cell lymphoma.
Xargay-Torrent S; López-Guerra M; Montraveta A; Saborit-Villarroya I; Rosich L; Navarro A; Pérez-Galán P; Roué G; Campo E; Colomer D
Clin Cancer Res; 2013 Feb; 19(3):586-97. PubMed ID: 23231952
[TBL] [Abstract][Full Text] [Related]
43. The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials Group.
Seftel MD; Kuruvilla J; Kouroukis T; Banerji V; Fraser G; Crump M; Kumar R; Chalchal HI; Salim M; Laister RC; Crocker S; Gibson SB; Toguchi M; Lyons JF; Xu H; Powers J; Sederias J; Seymour L; Hay AE
Leuk Lymphoma; 2017 Jun; 58(6):1358-1365. PubMed ID: 27750483
[TBL] [Abstract][Full Text] [Related]
44. Adhesion to bone marrow stroma inhibits apoptosis of chronic lymphocytic leukemia cells.
Lagneaux L; Delforge A; De Bruyn C; Bernier M; Bron D
Leuk Lymphoma; 1999 Nov; 35(5-6):445-53. PubMed ID: 10609782
[TBL] [Abstract][Full Text] [Related]
45. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
[TBL] [Abstract][Full Text] [Related]
46. Composite mantle cell lymphoma and small lymphocytic lymphoma in a lymph node.
Mass J; Alobeid B
Blood; 2021 Jan; 137(2):282. PubMed ID: 33443558
[No Abstract] [Full Text] [Related]
47. A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas.
Lwin T; Zhao X; Cheng F; Zhang X; Huang A; Shah B; Zhang Y; Moscinski LC; Choi YS; Kozikowski AP; Bradner JE; Dalton WS; Sotomayor E; Tao J
J Clin Invest; 2013 Nov; 123(11):4612-26. PubMed ID: 24216476
[TBL] [Abstract][Full Text] [Related]
48. VLA-4 mediated adhesion to bone marrow stromal cells confers chemoresistance to adherent lymphoma cells.
Weekes CD; Kuszynski CA; Sharp JG
Leuk Lymphoma; 2001 Feb; 40(5-6):631-45. PubMed ID: 11426535
[TBL] [Abstract][Full Text] [Related]
49. Identification and validation of seven genes, as potential markers, for the differential diagnosis of small B cell lymphomas (small lymphocytic lymphoma, marginal zone B cell lymphoma and mantle cell lymphoma) by cDNA macroarrays analysis.
Thieblemont C; Chettab K; Felman P; Callet-Bauchu E; Traverse-Glehen A; Berger F; Dumontet C; Cerutti C; Baseggio L; Salles G; Paultre C; Coiffier B; McGregor JL
Leukemia; 2002 Nov; 16(11):2326-9. PubMed ID: 12399979
[No Abstract] [Full Text] [Related]
50. Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells.
Purroy N; Carabia J; Abrisqueta P; Egia L; Aguiló M; Carpio C; Palacio C; Crespo M; Bosch F
Oncotarget; 2017 Jan; 8(1):742-756. PubMed ID: 27888629
[TBL] [Abstract][Full Text] [Related]
51. Mantle cell lymphoma concurrent with T-large granular lymphocytic leukemia: report of a case and review of literature.
Xiao Z; Ni Y; Yin G; Wu H; Li J; Miao K
Int J Clin Exp Pathol; 2015; 8(3):3365-9. PubMed ID: 26045870
[TBL] [Abstract][Full Text] [Related]
52. Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma.
Rinaldi A; Kwee I; Taborelli M; Largo C; Uccella S; Martin V; Poretti G; Gaidano G; Calabrese G; Martinelli G; Baldini L; Pruneri G; Capella C; Zucca E; Cotter FE; Cigudosa JC; Catapano CV; Tibiletti MG; Bertoni F
Br J Haematol; 2006 Feb; 132(3):303-16. PubMed ID: 16409295
[TBL] [Abstract][Full Text] [Related]
53. High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma.
Islam TC; Asplund AC; Lindvall JM; Nygren L; Liden J; Kimby E; Christensson B; Smith CI; Sander B
Leukemia; 2003 Sep; 17(9):1880-90. PubMed ID: 12970790
[TBL] [Abstract][Full Text] [Related]
54. Trisomy 12-associated, t(11;14)-negative mature B-cell leukemia with gene expression profile resembling mantle cell lymphoma.
Finn WG; Sreekumar A; Menon A; Utiger C; Chinnaiyan A
Leuk Lymphoma; 2006 Jan; 47(1):121-7. PubMed ID: 16321836
[TBL] [Abstract][Full Text] [Related]
55. Immunohistochemical characteristics of monocytoid B cell lymphoma, mantle zone lymphoma, small lymphocytic lymphoma (or B chronic lymphocytic leukemia), and hairy cell leukemia.
Oka K; Mori N; Yatabe Y
Acta Haematol; 1993; 90(2):84-9. PubMed ID: 8285023
[TBL] [Abstract][Full Text] [Related]
56. Polymorphism in the CD5 gene promoter in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.
Pérez-Chacón G; Contreras-Martín B; Cuní S; Rosado S; Martín-Donaire T; Losada-Fernández I; Vargas JA; Jordá J; Alvarez N; García-Marco J; Pérez-Aciego P
Am J Clin Pathol; 2005 May; 123(5):646-50. PubMed ID: 15981803
[TBL] [Abstract][Full Text] [Related]
57. [Application of gene expression profiling in molecular classification, prognosis and therapy of B-cell lymphoma].
Mao ZR; Zhou R; Zhang XX; Mueller-Hermelink Hk; Rosenwald A
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):785-9. PubMed ID: 20079025
[No Abstract] [Full Text] [Related]
58. Reactive oxygen species mediate cancer stem-like cells and determine bortezomib sensitivity via Mcl-1 and Zeb-1 in mantle cell lymphoma.
Luanpitpong S; Poohadsuan J; Samart P; Kiratipaiboon C; Rojanasakul Y; Issaragrisil S
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3739-3753. PubMed ID: 30251692
[TBL] [Abstract][Full Text] [Related]
59. Effects of lymph node stromal cells on the differentiation of a cell line established from an atypical prolymphocytic leukemia with phenotypes of both chronic lymphocytic and hairy cell leukemias.
Takeuchi H; Amano Y; Katayama I
Leuk Lymphoma; 1994; 14 Suppl 1():49-56. PubMed ID: 7820053
[TBL] [Abstract][Full Text] [Related]
60. Access to follicular dendritic cells is a pivotal step in murine chronic lymphocytic leukemia B-cell activation and proliferation.
Heinig K; Gätjen M; Grau M; Stache V; Anagnostopoulos I; Gerlach K; Niesner RA; Cseresnyes Z; Hauser AE; Lenz P; Hehlgans T; Brink R; Westermann J; Dörken B; Lipp M; Lenz G; Rehm A; Höpken UE
Cancer Discov; 2014 Dec; 4(12):1448-65. PubMed ID: 25252690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]